Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
North African scorpion venom neurotoxins are a complex group of small, basic peptides (typically 60-70 amino acids) primarily produced by scorpions of the Buthidae family, including the genera Androctonus and Leiurus (PubMed: 12643287). These toxins are highly potent and specifically target voltage-gated ion channels, most notably sodium (NaV) and potassium (KV) channels, in the nervous and muscular systems (UniProt: P01484). Alpha-toxins bind to Site 3 of NaV channels to inhibit inactivation, while beta-toxins bind to Site 4 to shift the voltage-dependence of activation, both resulting in prolonged depolarization and a massive, life-threatening release of catecholamines and acetylcholine (PubMed: 11403852). This "autonomic storm" leads to severe clinical manifestations such as hypertension, cardiac arrhythmias, and acute pulmonary edema (StatPearls: NBK482431). While these neurotoxins are the primary agents of morbidity in scorpion stings, they are also essential tools in neurobiology for characterizing ion channel structure and function. Therapeutic management relies heavily on the administration of specific antivenoms that neutralize the toxins before they can bind to their physiological targets (WHO: Scorpion Sting).
Antivenoms consist of specific antibodies or F(ab')2 fragments that bind to the neurotoxins with high affinity, neutralizing their ability to interact with voltage-gated ion channels and facilitating their clearance from the systemic circulation (PubMed: 11403852).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on North African scorpion venom neurotoxins.